相关实验视频
Updated: Jul 11, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
静血剂不会显著影响腹部身体轮的血清瘤形成
Hayeem L Rudy1, Peter Shamamian1, Julia Grande1
1Division of Plastic and Reconstructive Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
在腹部体形外科手术 (ABCS) 中,手术内静止剂不会增加血清瘤形成的风险. 这项研究发现血液静止剂使用与常见的术后并发症之间没有显著的关联.
科学领域:
- 整形外科 整形外科 整形外科
- 手术并发症 手术并发症
- 伤口愈合 治愈 伤口愈合
背景情况:
- 血清瘤形成是腹部身体轮手术 (ABCS) 后的常见并发症.
- 术内静止剂有时用于ABCS,并且有史以来与血清瘤发展有关.
研究的目的:
- 调查手术内静止剂的使用与ABCS后血清瘤形成的发生率之间的关联.
- 评估血液静止剂对其他术后并发症 (如血液瘤和静脉血栓栓塞) 的影响.
主要方法:
- 在2010年至2020年期间,对707名接受ABCS的患者进行了回顾性审查.
- 接受止血剂的患者与基于年龄,BMI和ASA得分的对照组相匹配1:2 .
- 收集的数据包括人口统计,手术细节和术后并发症.
主要成果:
- 在707名患者中,65人 (9.2%) 接受了静血剂,最常见的是局部血栓.
- 在病例和对照之间没有发现人口统计数据或并发症的显著差异.
- 两变量分析显示,血清瘤发育 (OR:0.83,p=0.781),血液瘤 (OR:3.72,p=0.060) 或静脉血栓栓塞 (OR:0.40,p=0.433) 没有显著差异.
结论:
- 在ABCS中使用止血剂与血清瘤风险增加没有显著关联.
- 该研究发现,血静剂对血液瘤,静脉血栓栓塞,伤口愈合延迟或伤口脱光没有显著的影响.
更多相关视频
04:20A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
00:20A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
Published on: July 4, 2019
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care